MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 41 filers reported holding MEI PHARMA INC in Q2 2015. The put-call ratio across all filers is 3.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,000 | -22.2% | 5,118 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | +28.6% | 5,118 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | 0.0% | 5,118 | -9.1% | 0.00% | – |
| Q1 2016 | $7,000 | -22.2% | 5,628 | 0.0% | 0.00% | – |
| Q4 2015 | $9,000 | +12.5% | 5,628 | +10.9% | 0.00% | – |
| Q3 2015 | $8,000 | -11.1% | 5,076 | 0.0% | 0.00% | – |
| Q2 2015 | $9,000 | +12.5% | 5,076 | +12.8% | 0.00% | – |
| Q1 2015 | $8,000 | -55.6% | 4,499 | +3.9% | 0.00% | – |
| Q4 2014 | $18,000 | -14.3% | 4,332 | +42.9% | 0.00% | – |
| Q3 2014 | $21,000 | +10.5% | 3,032 | +3.8% | 0.00% | – |
| Q2 2014 | $19,000 | -94.9% | 2,921 | -91.3% | 0.00% | -100.0% |
| Q1 2014 | $372,000 | +44.7% | 33,418 | +4.1% | 0.00% | – |
| Q4 2013 | $257,000 | -14.9% | 32,107 | +19.7% | 0.00% | – |
| Q3 2013 | $302,000 | +75.6% | 26,831 | +11.4% | 0.00% | – |
| Q2 2013 | $172,000 | – | 24,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 600,000 | $1,074,000 | 0.22% |
| Iguana Healthcare Management, LLC | 150,000 | $269,000 | 0.11% |
| Endurant Capital Management LP | 95,438 | $171,000 | 0.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,568 | $1,437,000 | 0.05% |
| Opus Point Partners Management, LLC | 30,000 | $54,000 | 0.04% |
| Carnick & Kubik, LLC | 30,355 | $54,000 | 0.04% |
| GREAT POINT PARTNERS LLC | 52,254 | $94,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 296,491 | $531,000 | 0.02% |
| Ancora Advisors LLC | 0 | $146,000 | 0.02% |
| SIMPLEX TRADING, LLC | 70,249 | $125,000 | 0.02% |